KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Gross Margin (2016 - 2025)

Historic Gross Margin for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to 70.11%.

  • Exact Sciences' Gross Margin rose 10600.0% to 70.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 69.69%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 69.69% for FY2025, which is 1400.0% up from last year.
  • Per Exact Sciences' latest filing, its Gross Margin stood at 70.11% for Q4 2025, which was up 10600.0% from 68.64% recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' Gross Margin peaked at 74.87% during Q4 2021, and registered a low of 46.86% during Q4 2022.
  • For the 5-year period, Exact Sciences' Gross Margin averaged around 67.12%, with its median value being 69.59% (2024).
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by -280100bps in 2022, then skyrocketed by 233100bps in 2023.
  • Exact Sciences' Gross Margin (Quarter) stood at 74.87% in 2021, then crashed by -37bps to 46.86% in 2022, then soared by 50bps to 70.17% in 2023, then fell by -2bps to 69.05% in 2024, then rose by 2bps to 70.11% in 2025.
  • Its Gross Margin stands at 70.11% for Q4 2025, versus 68.64% for Q3 2025 and 69.35% for Q2 2025.